3 Months After Launching a Phase Ib Trial, Janssen Terminates Collaboration Deal with Aduro Biotech 0 02.10.2018 03:00 Feedity.com Janssen Biotech, a Johnson & Johnson company, informed Aduro Biotech that it was terminating its research and license deals related to Aduro’s Listeria treatment for cancers. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
